חזרה לתוצאות החיפוש

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Sickle Cell Disease

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • University Of Alabama, Birmingham, Alabama, United States

    Contact: Study coordinator (Jeanine Dumas) · jdumas@uabmc.edu · +1 205 638 9285
    Contact: Principal Investigator (Chibuzo Churchill Ilonze)

  • Ctr for Inherited Blood Disorders, Orange, California, United States

    Contact: Study coordinator (Emily Lopez) · elopez@cibd-ca.org
    Contact: Principal Investigator (Vanessa Salinas)

  • Childrens National Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Taylor Quinn) · tquinn@childrensnational.org · 202-476-5000
    Contact: Principal Investigator (Andrew Campbell)

  • University of Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Tatiana Elias-Grajeda) · tatiana.elias-grajeda@jax.ufl.edu
    Contact: Principal Investigator (Gabriela Bastidas)

  • Augusta University Georgia, Augusta, Georgia, United States

    Contact: Study coordinator (Latanya Bowman) · lbowman@augusta.edu · 706-721-2941
    Contact: Principal Investigator (Abdullah Kutlar)

  • WCG Sonar Clinical Research, Riverdale, Georgia, United States

    Contact: Study coordinator (Ify Anierobi) · ianierobi@sonarcr.com
    Contact: Principal Investigator (Anthony Onyegbula)

  • Norton Children s Hospital, Louisville, Kentucky, United States

    Contact: Study coordinator (Meagan Despain) · meagan.despain@louisville.edu
    Contact: Principal Investigator (Ashok Raj)

  • The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

    Contact: Study coordinator (Goodness Che) · anchang1@jhmi.edu · 410-955-2812
    Contact: Principal Investigator (Lydia Pecker)

  • Southern Specialty Research, Flowood, Mississippi, United States

    Contact: Study coordinator (Wendy Thomson) · wendy.thomson@southernspecialty.org
    Contact: Principal Investigator (Sharon Pennington)

  • Childrens Hospital at Montefiore, The Bronx, New York, United States

    Contact: Study coordinator (Karen Ireland) · kireland@montefiore.org · 718-741-2384
    Contact: Principal Investigator (Kaitlin Strumph)

  • East Carolina University, Greenville, North Carolina, United States

    Contact: Study coordinator (Tori Donadio) · donadiov21@ecu.edu
    Contact: Principal Investigator (Beng Fuh)

  • Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States

    Contact: Study coordinator (Julie Fountain) · julie.fountain@advocatehealth.org
    Contact: Principal Investigator (Alex George)

  • Spoknwrdclinicaltrials, Easton, Pennsylvania, United States

    Contact: Study coordinator (Anne Murunga) · amurunga@spoknwrdclinicaltrials.com
    Contact: Principal Investigator (Hayman Salib)

  • U of TX Health Science Ct, Houston, Texas, United States

    Contact: Study coordinator (Eyuel Baherey) · Eyuel.L.Baherey@uth.tmc.edu
    Contact: Principal Investigator (Modupe Idowu)

  • Novartis Investigative Site, Salvador, Estado de Bahia, Brazil

  • Novartis Investigative Site, São Luís, Maranhão, Brazil

  • Novartis Investigative Site, Campinas, São Paulo, Brazil

  • Novartis Investigative Site, Ribeirão Preto, São Paulo, Brazil

  • Novartis Investigative Site, Sao Jose Rio Preto, São Paulo, Brazil

  • Novartis Investigative Site, São Paulo, São Paulo, Brazil

  • Novartis Investigative Site, São Paulo, São Paulo, Brazil

  • Novartis Investigative Site, Medellín, Antioquia, Colombia

  • Novartis Investigative Site, Cali, Valle del Cauca Department, Colombia

  • Novartis Investigative Site, Cali, Valle del Cauca Department, Colombia

  • Novartis Investigative Site, Montería, Colombia

  • Novartis Investigative Site, Ahero, Kisumu County, Kenya

  • Novartis Investigative Site, Kisumu, Kenya

  • Novartis Investigative Site, Kisumu, Kenya

  • Novartis Investigative Site, Siaya, Kenya

  • Novartis Investigative Site, Kampala, Uganda

  • Novartis Investigative Site, Masaka, Uganda

  • Novartis Investigative Site, Tororo, Uganda

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)